Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $5.28 on 10/8/25 after a major increase of 11.6%. Moreover, this advance was accompanied by exceptionally high trading volume at 205% of normal. The stock has risen 13.1% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Voyager Therapeutics has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Voyager Therapeutics has a neutral Appreciation Score of 46 but a poor Power Rating of 17, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment